Thus, we followed patients from cohort entry until the outcome (detailed below), switching or discontinuation of study drug (defined as the lack of a prescription by the end of the 90 day grace period), death from any cause other than suicide, end of registration with the CPRD, or end of the study period (29 March 2021), whichever occurred first
In our experience working with research teams, reconstitution errors and improper storage account for more failed protocols than dosing mistakes
Odd-chain fatty acids as a biomarker for dietary fiber intake: a novel pathway for endogenous production from propionate
This is an important question to discuss with your prescribing clinician before starting any medication that affects appetite
If you have questions about peptide therapy, dosing, or whether this option is right for you, please contact us directly
The growing retatrutide conversation also offers an early view into how patient expectations and narratives can develop well before a treatment reaches the market
